Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Career intentions and practice expectations among French residents and early-career dermatologists.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Breast cancer survivors' perceptions of cardiovascular risk following radiotherapy in the United Kingdom.

Radiography (London, England : 1995)·2025
Same author

Feeding the cosmos: tackling personalized space nutrition and the leaky gut challenge.

NPJ microgravity·2025
Same author

Mouse organoids as an in vitro tool to study the in vivo intestinal response to cytotoxicants.

Archives of toxicology·2022
Same author

Predicting cow milk quality traits from routinely available milk spectra using statistical machine learning methods.

Journal of dairy science·2021
Same author

Simulation-based acquisition of non-technical skills to improve patient safety.

Seminars in pediatric surgery·2020

相关实验视频

Updated: Jul 17, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

在头部创伤后,大脑中的β A4粉样蛋白沉积.

G W Roberts1, S M Gentleman, A Lynch

  • 1Department of Anatomy, St Mary's Hospital Medical School, Imperial College of Science, Technology and Medicine, London, UK.

Lancet (London, England)
|December 7, 1991
PubMed
概括

严重的头部损伤可以迅速触发大脑中的β A4粉样蛋白沉积. 这项研究发现38%的患者在头部创伤几天内发现了广泛的β A4粉样蛋白斑块.

科学领域:

  • 神经科学是一个神经科学.
  • 神经病理学神经病理学
  • 创伤性脑损伤 创伤性脑损伤

背景情况:

  • 以前的研究将头部创伤与长期幸存者的β A4粉样蛋白斑块联系起来.
  • 人们对头部损伤对粉样蛋白沉积的急性影响不太了解.

研究的目的:

  • 调查严重头部损伤诱导βA4粉样蛋白快速沉积的可能性.
  • 为了检查头部创伤的短期幸存者的粉样斑块形成.

主要方法:

  • 研究了16名头部严重受伤的患者 (年龄在10-63岁之间),他们存活了6-18天.
  • 使用了针对β A4粉样蛋白特异性抗体的免疫染.

主要成果:

  • 在16名患者中有6名 (38%) 的大脑皮层中观察到大量的βA4粉样蛋白沉积物.
  • 这些发现表明,严重头部损伤后粉样蛋白沉积迅速.

结论:

  • 严重的头部损伤可以在几天内在大脑中启动βA4粉样蛋白沉积.
  • 这表明一种潜在的机制将急性脑创伤与早期神经病理变化联系起来.

更多相关视频

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain
09:00

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain

Published on: April 28, 2022

相关实验视频

Last Updated: Jul 17, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain
09:00

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain

Published on: April 28, 2022